Bregje Christiaenssen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bregje Christiaenssen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andy Wullaert
Cell Death Signaling Laboratory, Infla-Med Centre of Excellence, Department of Biomedical Sciences, University of Antwerp
1 shared publication Arinna Bertoni
UOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy
1 shared publicationBenson Ogunjimi
Antwerp Center for Translational Immunology and Virology (ACTIV), Center for Health Economics Research and Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium
1 shared publication- Esther Hoste
VIB Center for Inflammation Research, Ghent, Belgium
1 shared publication - Fleur Boone
VIB Center for Inflammation Research, 9052 Ghent, Belgium
1 shared publication - Geert van Loo
VIB Center for Inflammation Research, 9052 Ghent, Belgium
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Springer Nature in Cell Death & Differentiation
PAD4-generated citrullinated histones are triggers for autoinflammation in cryopyrin-associated periodic syndrome
Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory disorders caused by gain-of-function NLRP3 variants. Although NLRP3 inflammasomes mediate IL-1β secretion through Gasdermin D (GSDMD), we show that GSDMD deletion did not prevent autoinflammation in mice ubiquitously expressing the Nlrp3 A350V variant. Inflamed skin of Nlrp3 A350V -expressing GSDMD-deficient mice displayed citrullinated histone 3-containing neutrophil extracellular traps (CitH3-NETs). CitH3-NETs induced IL-1β secretion from murine Nlrp3 A350V -expressing GSDMD-deficient macrophages as well as from human CAPS patient monocytes and macrophages. Blocking protein arginine deiminase-4 (PAD4) prevented CitH3 release and disabled the IL-1β-inducing NET effects, identifying CitH3 as crucial trigger. Mechanistically, CitH3-NETs activated GSDME in GSDMD-deficient Nlrp3 A350V macrophages, and GSDME deletion prevented pathology in Nlrp3 A350V -expressing GSDMD-deficient mice. In addition to this GSDME-dependent autoinflammation axis, PAD4 deletion also prevented autoinflammation in mice with neutrophil-specific Nlrp3 A350V expression that develop CAPS in a GSDMD-dependent manner. These observations support a CAPS model in which PAD4-mediated CitH3-NET release can trigger both GSDMD-dependent and GSDME-dependent autoinflammation.
- 15 July 2026
- Published by Springer Nature in Cell Death & Differentiation
Open AccessPAD4-generated citrullinated histones are triggers for autoinflammation in cryopyrin-associated periodic syndrome
Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory disorders caused by gain-of-function NLRP3 variants. Although NLRP3 inflammasomes mediate IL-1β secretion through Gasdermin D (GSDMD), we show that GSDMD deletion did not prevent autoinflammation in mice ubiquitously expressing the Nlrp3 A350V variant. Inflamed skin of Nlrp3 A350V -expressing GSDMD-deficient mice displayed citrullinated histone 3-containing neutrophil extracellular traps (CitH3-NETs). CitH3-NETs induced IL-1β secretion from murine Nlrp3 A350V -expressing GSDMD-deficient macrophages as well as from human CAPS patient monocytes and macrophages. Blocking protein arginine deiminase-4 (PAD4) prevented CitH3 release and disabled the IL-1β-inducing NET effects, identifying CitH3 as crucial trigger. Mechanistically, CitH3-NETs activated GSDME in GSDMD-deficient Nlrp3 A350V macrophages, and GSDME deletion prevented pathology in Nlrp3 A350V -expressing GSDMD-deficient mice. In addition to this GSDME-dependent autoinflammation axis, PAD4 deletion also prevented autoinflammation in mice with neutrophil-specific Nlrp3 A350V expression that develop CAPS in a GSDMD-dependent manner. These observations support a CAPS model in which PAD4-mediated CitH3-NET release can trigger both GSDMD-dependent and GSDME-dependent autoinflammation.